Crossmark

Correction to: Advanced glycation end products, advanced oxidation protein products, and ferric reducing ability of plasma in patients with rheumatoid arthritis: a focus on activity scores

Crossref DOI link: https://doi.org/10.1007/s10067-021-05823-3

Published Online: 2021-07-01

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Najafizadeh, Seyed Reza

Amiri, Khatereh

Moghaddassi, Maryam

Khanmohammadi, Shaghayegh

Mirmiranpour, Hossein

Nakhjavani, Manouchehr
License Information

Text and Data Mining valid from 2021-07-01

Version of Record valid from 2021-07-01
More Information

Article History

First Online: 1 July 2021

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below